Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinovant Sciences
Shanghai, Shanghai, Chinasinovant.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Sinovant has advanced several innovative medicines addressing major public health needs in China, including liver cancer and drug-resistant infections. Its pipeline includes small molecule drugs in Phase 2 trials for GI and oncology indications, as well as earlier-stage dermatology programs. The company outlicensed its antibiotic lefamulin to Sumitomo after successful Chinese trials showing non-inferiority to moxifloxacin for pneumonia.[7] It also co-founded Cytovant to develop cell therapies targeting Asian patient populations.[8]
- Therapeutic areas
- OncologyImmunologyDermatologyUrologyGastroenterologyInfectious Diseases
- Modalities
- Small molecules[3]Cellular therapies (via subsidiary Cytovant)[8]
- Industry
- Biotech
02
Partnerships
Medigene AG – multi-program license/collaboration agreement for T-cell immunotherapies via Cytovant subsidiary [8].Renexxion – naronapride development rights for China [6].Sumitomo Dainippon Pharma – acquired Chinese rights to lefamulin antibiotic from Sinovant [7].
Beyond the preview
Go deeper on Sinovant Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sinovant Sciences.